Abstract. Human embryonic stem cells (HESCs) are defined as self-renewing cells that retain their ability to differentiate into all cell types of the body. They have enormous potential in medical applications and as a model for early human development. There is a need for derivation of new HESC lines to meet emerging requirements for their use in cell replacement therapies, disease modeling, and basic research. Here, we describe a modified culture medium containing human recombinant leukemia inhibitory factor and human basic fibroblast growth factor that significantly increases the number of human blastocysts formed and their quality, as well as the efficiency of HESC derivation from poor-quality embryos. Culturing poor-quality embryos in modified medium resulted in a two-fold increase in the blastocyst formation rate and a seven-fold increase over the derivation efficiency in conventional medium. We derived 15 HESC lines from poor-quality embryos cultured in modified culture medium and two HESC lines from quality embryos cultured in conventional culture medium. All cell lines shared typical human pluripotent stem cell features including similar morphology, normal karyotypes, expression of alkaline phosphatase, pluripotency genes, such as Oct4, and cell surface markers (SSEA-4, TRA-1-60, TRA-1-81), the ability to form teratomas in SCID mice, and the ability to differentiate into cells of three embryonic germ layers in vitro. Our data suggest that poor-quality embryos that have reached the blastocyst stage in our modified culture medium are a robust source for normal HESC line derivation. Key words: Derivation, Human embryonic stem cells, Modified culture medium, Poor-quality embryos (J. Reprod. Dev. 56: [533][534][535][536][537][538][539] 2010) uman embryonic stem cell (HESC) lines are typically derived from the inner cell masses (ICM) of blastocyst-stage embryos [1] . HESCs are self-renewing and have the ability to differentiate into all cell types. These characteristics provide HESCs with great potential for use in modern regenerative medicine and cell-based drug discovery.
(J. Reprod. Dev. 56: 533-539, 2010) uman embryonic stem cell (HESC) lines are typically derived from the inner cell masses (ICM) of blastocyst-stage embryos [1] . HESCs are self-renewing and have the ability to differentiate into all cell types. These characteristics provide HESCs with great potential for use in modern regenerative medicine and cell-based drug discovery.
Currently, the vast majority of HESC lines are derived from surplus cryopreserved embryos for in vitro fertilization (IVF) treatments [1, 2] . These embryos are developed to the blastocyst stage using in vitro culture prior to being plated for derivation purposes. However, the use of embryos and derivation of HESCs for research and eventual medical application has resulted in polarized ethical debates [3] , since the process involves the destruction of viable developing human embryos [1] . Therefore, it is difficult to obtain good quality embryos for research purposes. During the IVF process, only a small number of all IVF zygotes will develop successfully to the blastocyst stage [3, 4] . Most of these embryos display abnormal or delayed cell division, frequently accompanied by cellular fragmentation and developmental arrest before the blastocyst stage [4, 5] . These embryos, which display poor morphology, are routinely discarded because they are unlikely to establish pregnancy. Therefore, poor-quality embryos are a more accessible and abundant source of embryos that could be used for HESC derivation. Additionally, poor-quality embryos are considered to be less ethically controversial.
Although such poor-quality embryos have been used to derive HESC lines [6] [7] [8] [9] [10] [11] [12] , the efficiency of HESC derivation is very low. A major factor limiting the efficiency of HESC derivation is the poor-quality blastocysts developed from IVF of poor-quality embryos. Previous reports have shown that the addition of recombinant hLIF to the embryo culture medium could promote blastocyst development in humans [13] . Furthermore, Mitalipova et al. demonstrated that addition of LIF and bFGF to the culture medium as a mitogen could enhance the proliferation of ICM cells from blastocyst stage embryos with limited cell numbers [6] . Therefore, we hypothesized that addition of LIF and bFGF into the culture medium might improve the development of poor-quality embryos. Here, we report a modified culture medium that significantly increases the number of human blastocysts formed and their quality and the efficiency of HESC derivation from poor-quality embryos.
Materials and Methods

Source of poor quality embryos
All poor-quality embryos donated for this research were obtained from stimulated patients undergoing IVF treatment at the Reproductive Medical Center, Third Affiliated Hospital of Guangzhou Medical College. From March 2007 to May 2009, 121 couples agreed to donate their poor-quality embryos for stem cell research after being clearly informed regarding all research details at our IVF center. We obtained 419 embryos from the 121 couples. The oocyte donor average age was 32.10 ± 3.78 years. The average number of retrieved oocytes was 12.35 ± 6.78. The average number of poor-quality embryos we obtained was 3.46 ± 1.41. The study was approved by the hospital's ethics committee.
Embryo culture
Embryos were morphologically graded, as described by Edwards [14] as follows grade 1, equal-sized symmetrical blastomeres; grade 2, uneven blastomeres with < 10% fragmentation; grade 3 (10-50%), blastomeric fragmentation; and grade 4 (>50%), blastomeric fragmentation embryos. Only grade 3 and grade 4 embryos that were not used for transfer or freezing on day 3 were uesd after obtaining the cumulative embryo score (CES). During March 2007-March 2008, 201 day-3 poor-quality embryos were received and cultured in conventional culture medium comprised of G2.5 medium supplemented with 10% human serum albumin (Vitrolife, Sweden). During April 2008-May 2009, 218 day-3 poorquality embryos were received and cultured in modified culture medium comprised of G2.5 medium supplemented with 2000 U/ml of human recombinant leukemia inhibitory factor (LIF, Chemicon, Temecula, CA, USA), 10 ng/ml of human basic fibroblast growth factor (bFGF, Invitrogen, Carlsbad, CA, USA) and 10% human serum albumin. The embryos were cultured for an additional 4 days at 37 C in 5% CO2.
Blastocyst formation
Embryos were cultured to the blastocyst stage in two kinds of culture medium. Blastocyst quality was defined according to the criteria presented by Gardner et al. [15] . Briefly, quality 1 describes an early blastocyst with the blastocoel occupying <50% of the volume, quality 2 describes an early blastocyst with the blastocoel expanded to 50-80% of the volume, quality 3 describes a non-expanded blastocyst with a large blastocoel, quality 4 describes an expanded blastocyst, quality 5 indicates that the blastocyst has started to hatch and quality 6 indicates that the blastocyst is completely hatched. The first letter describes the ICM: 'A' means a high number of tightly packed cells, 'B' means a few cells, loosely packed, and 'C' almost no cells. The second letter reflects the cell number in the trophectoderm: 'A' indicates many cells, 'B' means few cells and 'C' means almost no cells. For example, 6AA describes a hatched blastocyst possessing normal-looking cells in both the ICM and trophectoderm.
Mechanical isolation of the inner cell mass
On day 7, all blastocysts, especially expanded and hatched blastocysts, were used for isolation of the ICM. The zonae pellucidae of the blastocysts were removed by treatment with 0.5% pronase (Sigma, St. Louis, MO, USA) in PBS for 2 min, and then washed 2-3 times to remove pronase and the remaining zona pellucida. For mechanical isolation, after the zona-free blastocysts were transferred to a droplet of HESC culture medium, the blastocysts were held on the dish with a microholding pipette under a stereomicroscope, and a fine needle was used to cut and segregate the trophectoderm as much as possible until the ICM was exposed. All isolated ICMs were then placed on mitomycin C-treated murine embryonic fibroblast (MEF) feeder layers for further culture.
Propagation of HES cell lines
After 8-9 days of culture, colonies derived from the ICM were mechanically dispersed into 2-3 small clumps using a micropipette. The ICM clumps were then transferred to a fresh feeder layer. These cells were again mechanically dissociated during the initial 5 passages. After 5 passages, they were incubated in 1mg/ml collagenase IV (Gibco, Invitrogen, Carlsbad, CA, USA) for 20-25 min at 37 C before further culture on freshly prepared feeders. Cells were routinely passed every 4-5 days, and the medium was changed every day. The HESC culture medium was knockout Dulbecco's modified Eagle's medium (DMEM; Gibco) supplemented with 15% knockout serum replacement (SR, Gibco), 5% defined fetal bovine serum (FBS, HyClone, Logan, UT, USA), 2 mmol/l Lglutamine, 0.1 mmol/l β-mercaptoethanol, 0.1 mmol/l non-essential amino acids (NEAAs), 100 units/ml penicillin, 100 μg/ml streptomycin, 10 ng/ml bFGF (Invitrogen), and 2000 U/ml hLIF. After 10 passages, hLIF was not added to the culture medium.
Alkaline phosphatase staining and immunostaining
To detect alkaline phosphatase (AKP) activity, HESC colonies were fixed with 90% alcohol for 2 min, washed three times with Tween-BST solution (PBS with 1% bovine serum albumin and 0.2% Tween-20) and then stained with BCIP/NBT (alkaline phosphatase substrate solution, Maxim Biotech Inc., San Francisco, CA, USA) for 30 min. To detect HESC stage-specific embryonic markers, the colonies were fixed with 4% paraformaldehyde for 30 min, and then incubated with 4% goat serum for 1 h. Primary antibodies were stage-specific embryonic antigens (SSEA-1, SSEA-4) and tumor-rejection antigen (TRA-1-60, TRA-1-81; Chemicon) diluted 1:50 with PBS and incubated at room temperature for 1 h. The colonies were washed three times with Tween-BST solution for 5 min each, and then incubated for 30 min in the dark with the secondary antibody [goat anti-mouse immunoglobulin (Ig)G for SSEA-4, goat anti-mouse IgM for SSEA-1,TRA-1-60 and TRA-1-81]. All secondary antibodies were conjugated to fluorescein isothiocyanate (FITC) and diluted 1:100. Negative controls were carried out without the addition of the primary antibodies (data not shown). Hoechst 33342 was used for nuclear staining.
Expression of molecular markers in HESC lines
Total RNA was extracted from cells using the Trizol Kit (Invitrogen), and was transcribed into cDNA using oligo(dT) and Rever Tra Ace reverse transcriptase (Toyobo). PCR reactions were carried out by mixing 1 μl of cDNA template, 250 nM of each primer, 200 μM dNTP mixture and 1U of Taq DNA polymerase in a volume of 20 μl. Samples were amplified in a thermocycler.
Pluripotency molecular marker genes, including OCT4 and NANOG, and marker genes for differentiated HESC, such as AFP (endoderm), NEUROD1 (ectoderm) and HBZ (mesoderm), were analyzed ( Table 1 ). The PCR amplified products were analyzed in a 1.5% agarose gel and visualized by ethidium bromide (Invitrogen) staining.
Karyotype analysis
For chromosome analysis, HESCs obtained after every 10 passages were incubated in culture medium with 0.25 μg/ml colcemid (Gibco) for 4 h, harvested, and incubated and 0.4% sodium citrate, 0.4% chloratum Kaliumat (1:1, v/v) at 37 C for 5 min and then fixed in methanol:acetic acid (3:1, v/v) three times. After Giemsa staining, at least 20 cells were examined in each group for chromosome analysis.
In vitro differentiation
To investigate the differentiation of HESCs in vitro, HESC colonies were dissociated with 1 mg/ml collagenase IV, and the suspension was cultured on bacterial culture plates to allow aggregation and prevent adherence to the plate. After culture for 3 days, the cells were transferred to a new bacterial culture plate, and the culture medium was changed. After suspension culture for 7 days, the formation of embryoid bodies (EBs) was examined. The EBs were transferred to 0.1% a gelatin-coated culture dish for spontaneous differentiation. Total RNA was extracted from the EB cells for analysis of the differentiated marker genes after 14 days of differentiation. The EB culture medium was equivalent to the HESC culture medium, except that it lacked bFGF and hLIF.
In vivo differentiation
The HESC colonies from passage 15 or beyond were digested with 0.05% trypsin EDTA solution for 2-3 min, and then dispensed into 300-400 small ES colony suspensions. The colonies were collected and subcutaneously injected into the inguinal grooves of 6-week-old male severe combined immunodeficiency (SCID) mice (two or more mice per cell line). Eight weeks later, the resultant tumors were removed, fixed for 4-8 h in 4% paraformaldehyde and embedded in paraffin. After staining with hematoxylin and eosin, the sections were examined for the presence of tissues derived from the three germ layers under a light microscope.
Statistical analysis
The results were compared using the SPSS 11.0 sofware (SPSS, Chicago, IL, USA). χ 2 test (P<0.05) was used to analyze the results presented in Fig. 2 .
Results
The effect of media conditions on blastocyst formation and quality in vitro
For the present study, our laboratory received a total 419 poorquality embryos (299 grade 3 embryos and 120 grade 4 embryos; Fig. 1A (Fig. 1B) . In the conventional culture group, 50.2% (101/201) of the embryos were at the 2-4 cell stage, 23.4% (47/201) were at the 6-8 cell stage and 26.4% (53/201) were severely fragmented. Twenty-nine (14.4%, 29/201) embryos developed to blastocysts, and 6 (2.99%, 6/201) blastocysts were scored as grade A. All of the blastocysts were used to attempt HESC line derivations (Fig. 2) .
Derivation of HESC lines
In the conventional culture medium group, 29 blastocysts were used to isolate ICMs. Of the fourteen ICMs attached to the feeder layer, 5 started to grow out. Two permanent HESC lines were obtained (FY-hES-9 and FY-hES-10; we have previously derived eight HESC lines). In the modified culture medium group, 62 blastocysts were used to isolate ICMs. Of the 39 ICMs attached to the feeder layer, 26 started to grow out. Fifteen HESC lines were produced (FY-hES-11 to 25). The derivation efficiency using day-3 poor-quality embryos cultured in conventional culture medium was only 1.0% (2/201). In contrast, the derivation efficiency using day-3 poor-quality embryos cultured in modified culture medium was significantly higher (6.9%, 15/218; P=0.00228) than for the embryos cultured in conventional culture medium (Fig. 2) .
Characterization of HESC lines
All seventeen HESC lines exhibited AKP (Fig.1D) activity, SSEA-4, TRA-1-60, TRA-1-81, but not SSEA-1 (Fig. 3) . Karyotyping of the seventeen HESC lines revealed that these lines had normal 46,XX or 46,XY karyotypes (Fig. 4) . OCT4 and Nanog, which are specific marker genes for undifferentiated HESCs, were expressed in the cell lines (Fig. 5A, Table 2 ).
In vitro and in vivo differentiation potential of HESC lines
EBs were formed from each HESC line. Differentiated HESC marker genes, such as AFP (endoderm), NEUROD1 (ectoderm) and HBZ (mesoderm), were expressed in the HESC cell lines (Fig.  5B ). The results demonstrate that these cells can differentiate into three germ layers in vitro.
Teratomas were first observed 4-5 weeks after the HESCs were injected into SCID mice. Histological examination revealed that the teratomas contained the tissues of three embryonic germ layers, including the endoderm (glandular tissue), mesoderm (fat cells) and ectoderm (squamous cells; Fig. 6 ).
Discussion
HESCs possess a huge potential for modern regenerative medicine. To use HESCs in cell-based therapies, it is necessary to obtain enough cell lines to cover the vast spectrum of transplant Scale bar=50 μm. antigens and to avoid rejection [16] . It was initially proposed that a minimum of 40-50 homozygous HESC lines would be necessary to cover approximately 50% of the human leukocyte antigen (HLA) isotypes in the American population and thus minimize the immune rejection of HESC-derived transplants [17] . More recently, the number of HESC lines needed in a stem bank for HLA matching of the UK population has been calculated to be approximately 150 [16] , but this number may underestimate the lines necessary to match a very ethnically diverse population [18, 19] . Therefore, efficient derivation of more cell lines will facilitate the construction of a bank of HESC lines with diverse HLA genotypes that can serve most of the patients within a given region. Although recent reports suggest that HESCs are derived more efficiently from highquality embryos [20, 21] , it is difficult to obtain good-quality human embryos for HESC derivation. Therefore, embryos deemed clinically useless based on poor morphology are good resources for HESC production. However, the efficiency of producing HESCs from these cells has been disappointingly low. One group cultured 130 day-3 poor-quality embryos with conventional culture medium, resulting in 19 blastocysts (15%) from which two lines were derived (1.5%) [7] . Another group cultured 321 day-3 poorquality embryos with conventional culture medium, resulting in 57 blastocysts (17%) from which one line was derived (0.3%) [11] .
In the present study, we cultured 218 day-3 poor-quality embryos using our modified culture medium, resulting in 62 blastocysts (28.4%) from which fifteen cell lines were derived (6.9%). In contrast, 201 day-3 poor-quality embryos were cultured in conventional culture medium, resulting in 29 blastocysts (14.4%) from which two cell lines were derived (1.0%). Culturing poor-quality embryos in modified medium resulted in a two-fold increase in the blastocyst formation rate and a 7-fold increase over the derivation efficiency obtained in conventional medium (28.4%, n=218 vs. 14.4%, n=201, respectively, P=0.00051; 6.9%, n=218 vs. 1.0%, n= 201, respectively, P=0.00228). Our results suggest that the modified culture medium significantly enhances the number of blastocysts and the efficiency of HESC derivation from poor-quality embryos. Twenty-five grade A blastocysts were obtained using the modified culture medium. However, in the conventional culture medium, 6 grade A blastocysts were generated (10.55%, n= 218 vs. 2.99%, n=201, respectively, P=0.00092). Embryo culture in the presence of LIF and bFGF caused an increase in the total cell number primarily because of a relatively larger ICM. Morphological assessment of the blastocysts showed that LIF and bFGF did alter the range of qualities seen in blastocysts yielded in the modified culture medium. Our results demonstrate that human embryo culture medium containing hLIF and bFGF could improve blastocyst quality. Recently, Kimber et al. have shown that human culture of human embryos in LIF appears to facilitate the expression of a number of genes, such as ERBB4. ERBB4 protein expression in human blastocysts is important for initial attachment to the luminal epithelium. Therefore, LIF might promote blastocyst attachment and implantation through facilitating upregulation of embryonic ERBB4 [22] . It would be interesting to investigate whether the blastocysts generated in the presence of LIF and bFGF have high levels of gene expression, such as for Oct4, Sox2 and Nanog, which are involved in ICM pluripotency.
Fifteen cell lines were derived from 62 blastocysts in total, 11 from 25 grade A blastocysts and 4 from 18 grade B blastocysts. Therefore, our higher derivation efficiency may be attributed to the improved blastocyst quality. Our HESC lines shared features with HESCs, as previously reported [1, 2] , including a similar morphology, normal karyotypes, expression of alkaline phosphatase and pluripotency genes, such as Oct4, and cell surface markers (SSEA-4, TRA-1-61, TRA-1-80) and the ability to form teratomas in SCID mice and to differentiate into cells of three embryonic germ layers in vitro. Specifically, two cell lines cultured beyond 60 passages maintained the same HESC marker characteristics and karyotypes exhibited in the initial cell passages. Recently, Lavon et al. reported derivation of euploid HESCs from aneuploid embryos; their results suggest that in vitro selection may occur in favor of euploid cells [23] . Aneuploidy and chromosomal mosaicism are often found in poor-quality embryos [24] , yet all of the cell lines derived by our group from poor-quality embryos thus far display a normal karyotype. Our results indicate that the process of HESC derivation rigorously selects for normal ploidy.
It has been reported that poor-quality embryos, without progression to the blastocyst stage, are a poor source for HESC line derivation [9, 10, 25] . In contrast, our data suggest that poor-quality embryos that have reached the blastocyst stage in our modified culture medium are a robust source of normal HESC line derivation. In our experience, hundreds of low morphological grade and low developmental potential embryos, which are destined to be discarded, can develop to the blastocyst stage and give rise to normal new HESC lines. This finding may facilitate the possibility of establishing hESC line banks worldwide. -hES  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  Passage  68  42  63  40  40  40  35  30  25  20  20  20  20  20  15  15  15  AKP  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  OCT4  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  SSEA-1  -----------------SSEA- 
